Cat.#: ACPP-1621
| Despition | LZIC Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1494 | beta Catenin Blocking Peptide (AC1494) | 250 µg | inquiry |
| ACPP-1032 | Recombinant Human PGRPS Protein (6×His Tag) (AC1032) | 50 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg | inquiry |
| ACPP-1363 | Presenilin 1 Blocking Peptide (AC1363) | 250 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1509 | Human APOD Protein, HEK (AC1509) | 2 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.